Daily SPAC Update – March 14, 2025

by | Mar 14, 2025

Finnovate Delays Deal Vote Again. Bannix Acquisition (BNIX) Extends. Bukit Jalil (BUJA) and Sk Growth (SKGR) Votes Set. Columbus Acquisition (COLA) Separate Trading.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
BNIX – BANNIX ACQUISITION CORP * Extend to Jun 14, 2025 * 225,082 redeemed * $2,572,687.26 removed * trust $11.43

SPAC DEAL & EXTENSION VOTES SET
BUJA – Bukit Jalil Global Acquisition 1 Ltd * DEAL VOTE SET: Mar 31, 2025 * trust $11.31
SKGR – Sk Growth Opportunities Corp * EXTENSION VOTE SET: Mar 27, 2025 * trust $11.69

SEPARATE WARRANTS/RIGHTS
Mar 17: COLUMBUS ACQUISITION CORP (COLA)

OTHER SPAC NEWS
DSAQ – DIRECT SELLING ACQUISITION CORP * Trust Update * trust $11.86
FNVTF – FINNOVATE ACQUISITION CORP * Deal Vote Postponed
SKGR – SK GROWTH OPPORTUNITIES CORP * Investor Deck
BHAC – FOCUS IMPACT BH3 ACQUISITION CO * Investor Deck

YESTERDAY’S TOP SPAC GAINERS
17.70% ~ $ 4.36 | BOWN – BOWEN ACQUISITION CORP (Announced)
.65% ~ $ 10.79 | HLXB – HELIX ACQUISITION CORP II (Announced)
.61% ~ $ 11.50 | ISRL – ISRAEL ACQUISITIONS CORP (Announced)
.46% ~ $ 10.95 | GATE – MARBLEGATE ACQUISITION CORP (Announced)
.30% ~ $ 10.02 | WLAC – WILLOW LANE ACQUISITION CORP (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-1.95% ~ $ 10.79 | IPXX – INFLECTION POINT ACQUISITION CORP II (Announced)
-.96% ~ $ 11.40 | FTII – FUTURETECH II ACQUISITION CORP (Announced)
-.61% ~ $ 6.56 | GLST – GLOBAL STAR ACQUISITION INC (Announced)
-.60% ~ $ 11.68 | AQU – AQUARON ACQUISITION CORP (Announced)
-.50% ~ $ 9.99 | DMAA – DRUGS MADE IN AMERICA ACQUISITION CORP (Pre-Deal)

LATEST SPAC IPO PERFORMANCE
Feb 27 | $ 10.05 | LOKV – Live Oak Acquisition Corp. V
Feb 27 | $ 10.04 | NHIC – NewHold Investment Corp. III
Feb 27 | $ 10.02 | FERA – Fifth Era Acquisition Corp I
Feb 26 | $ 10.04 | RAC – Rithm Acquisition Corp.
Feb 12 | $ 10.06 | AACB – Artius II Acquisition Inc.
Feb 12 | $ 10.13 | MAYA – Maywood Acquisition Corp.

Recent Analysis

Daily SPAC Update – April 16, 2025

Denali Capital Extension Approved. Compass Digital and Technology & Telecommunications Extension Votes Today. Pyrophyte Sets Extension Vote. Newhold III Separate Trading.

Daily SPAC Update – April 14, 2025

Ares Acquisition + Kodiak Robotics Deal Announced. More Deal Terminations. Focus Impact BH3 Extends and Auditor Changed. Altenergy and Healthcare AI Extension Votes Set.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.